ArticleBMC cancer2024

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement.

Lin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.